Kopra Bio
Genetically engineered viruses that teach your immune system to kill…
What they do
Current treatments fail to effectively cure aggressive cancers like glioblastoma by not generating a strong, durable anti-tumor immune response.
Kopra Bio develops genetically engineered oncolytic viruses that train the immune system to recognize and kill cancer cells.
Oncologists and hospitals treating cancer patients, initially neuro-oncology teams managing glioblastoma.
Founders
Neurosurgery resident @ UCSF, scientific co-founder @ Kopra Bio. Published over 70 peer-reviewed publications as a neurosurgery resident at UCSF. Alex is particularly interested in the delivery of cell and gene therapies to the central nervous system and neuro-oncology. Kopra Bio is a serial biotech entrepreneur and a UCSF Neurosurgery resident on a mission to revolutionize cancer treatment.
Company timeline
- Founded2024
- YC batchSummer 2024
- StatusActive
- Team size2 people
- LocationSan Francisco, CA, USA
Similar startups
